756 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Kingfisher Capital LLC

Kingfisher Capital LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, HoldingsChannel.com reports. The fund bought 756 shares of the biotechnology company’s stock, valued at approximately $302,000.

Other large investors have also recently bought and sold shares of the company. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the last quarter. 1832 Asset Management L.P. increased its holdings in Axon Enterprise by 44.0% during the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of Axon Enterprise by 13.9% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock valued at $108,496,000 after purchasing an additional 45,049 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on AXON. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Craig Hallum increased their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Robert W. Baird increased their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Barclays upped their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Insider Activity

In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The trade was a 4.20 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares of the company’s stock, valued at $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 210,256 shares of company stock worth $87,783,120. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $634.96 on Friday. The stock has a market cap of $48.42 billion, a price-to-earnings ratio of 164.07, a PEG ratio of 13.97 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock’s 50 day simple moving average is $478.27 and its two-hundred day simple moving average is $374.80. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $641.20.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.